For the past 20 years, this annual event has brought together companies in the nutraceutical industry to reward the most innovative players. Gnosis by Lesaffre created the first extruded nutritional yeast in the form of a small crisp.
The new functional beverages are available in four varieties
November 3, 2021
Each MycoBrew® drink mix is specially crafted with flavor-forward formulation, using carefully selected ingredients. Designed with the day-to-day in mind, each drink offers a distinct experience.
The new line of bars contains adaptogens, nootropics and organic botanicals
September 29, 2021
The new line contains four varieties: Energy, Focus, Immunity and Calm. Smpl simplifies the way consumers access superfoods by eliminating powders and pills in exchange for a healthy product that is available on the go.
New brand was founded by former track and field teammates
June 30, 2021
The company offers four powder blends: ‘Calm’, ‘Focus’, ‘Sleep’ and ‘Skin’, as well as four standalone jars of Ashwagandha Extract, Holy Basil [Tulsi] Extract, Lion’s Mane Extract and Mucuna Extract, that can be added to coffees, teas or more.
New product entry supports immune health, digestion, energy
June 15, 2021
Uncle Matt's Organic, launched an Ultimate Shots line crafted with functional ingredients and powerful probiotics. Uncle Matt's Organic Ultimate Shots aim to aid specific functions such as immune support, digestion and energy.
There’s a growing emphasis on mental and emotional wellbeing as consumers take a more holistic approach to health. That’s why Innova Market Insights identified “Mood: The Next Occasion,” as one of its Top Trends for 2021.
EpiCor Postbiotic offers immune support to foods, beverages
June 7, 2021
The US Food and Drug Administration (FDA) responded with a letter of no objection to Cargill’s GRAS (Generally Recognized As Safe) notification for EpiCor® postbiotic use in certain foods and beverages.
New patent approves Kemin BetaVia for immune strengthening
May 12, 2021
Kemin Industries has been granted a United States patent (US 10,912,794) on the use of beta 1,3 glucan for modulating human immune function and treating intestinal inflammation. This new patent joins a previously issued patent (US 9,574,217) on the production of beta-glucan for immune modulation using algae from a proprietary strain of Euglena gracilis, ATCC PTA-123017.